Add listing
    0
    Add listing

    Redbiotec AG Verified listing

    • Swiss Biotech Association
      Member

    Redbiotec was founded in 2006 as an ETH spin-off. Having sold its CMV vaccine business to Pfizer in 2015, Redbiotec has since developed potent HSV-2 immunotherapies, and a platform technology of engineered bacteria - BRISPR® - to deliver therapeutic cargos of various nature for the treatment of cancer and genetic disorders.

    Location
    Canton
    Facts & figures
    • Type of organization
      Private company
    • Year of foundation
      2006
    • Number of employees in Switzerland
      10-19
    Key business

    You may also be interested in